AAAAAA

   
Results: 1-17 |
Results: 17

Authors: Jonson, T Albrechtsson, E Axelson, J Heidenblad, M Gorunova, L Johansson, B Hoglund, M
Citation: T. Jonson et al., Altered expression of TGFB receptors and mitogenic effects of TGFB in pancreatic carcinomas, INT J ONCOL, 19(1), 2001, pp. 71-81

Authors: Ohlsson, B Borg, K Rehfeld, JF Axelson, J Sundler, F
Citation: B. Ohlsson et al., The method of administration of cholecystokinin determines the effects evoked in the pancreas, PANCREAS, 23(1), 2001, pp. 94-101

Authors: Monstein, HJ Ohlsson, B Axelson, J
Citation: Hj. Monstein et al., Differential expression of gastrin, cholecystokinin-A and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines, SC J GASTR, 36(7), 2001, pp. 738-743

Authors: Axelson, J
Citation: J. Axelson, Inside USB 2.0: what the new spec means for developers, EDN, 46(8), 2001, pp. 121

Authors: Lindell, G Hansson, L Dawiskiba, S Andersson, R Axelson, J Ihse, I
Citation: G. Lindell et al., Operations for extrahepatic bile duct cancers: Are the results really improving?, EURO J SURG, 166(7), 2000, pp. 535-539

Authors: Ohlsson, B Yusa, T Rehfeld, JF Lundquist, I Ihse, I Axelson, J
Citation: B. Ohlsson et al., Effects of intraluminal trypsin and bile on the exocrine and endocrine pancreas after pancreaticobiliary diversion and biliodigestive shunt, PANCREAS, 20(2), 2000, pp. 170-176

Authors: Kullenberg, B Jansen, C Fredang, N Ohlsson, B Axelson, J
Citation: B. Kullenberg et al., Transforming growth factor alpha (TGF-alpha) increases cell number in a human pancreatic cancer cell line but not in normal mouse pancreas, INT J PANCR, 28(3), 2000, pp. 199-205

Authors: Ohlsson, B Axelson, J Stenram, U Rehfeld, JF Ihse, I
Citation: B. Ohlsson et al., Acute taurodeoxycholate-induced pancreatitis in the rat is associated withhyperCCKemia, INT J PANCR, 27(3), 2000, pp. 195-201

Authors: Ohlsson, B Borg, K Mulder, H Rehfeld, JF Axelson, J Sundler, F
Citation: B. Ohlsson et al., Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas, SC J GASTR, 35(6), 2000, pp. 612-618

Authors: Johansson, A Axelson, J Ingvar, C Luttropp, HH Lundberg, J
Citation: A. Johansson et al., Preoperative ropivacaine infiltration in breast surgery, ACT ANAE SC, 44(9), 2000, pp. 1093-1098

Authors: Axelson, J Kobari, M Furukawa, T Matsuno, S
Citation: J. Axelson et al., Thymic carcinoid in the pancreas: Metastatic disease or new primary tumours, EURO J SURG, 165(3), 1999, pp. 270-273

Authors: Ihse, I Axelson, J Dawiskiba, S Hansson, L
Citation: I. Ihse et al., Pancreatic biopsy: Why? When? How?, WORLD J SUR, 23(9), 1999, pp. 896-900

Authors: Ihse, I Axelson, J Hansson, L
Citation: I. Ihse et al., Pancreaticogastrostomy after subtotal pancreatectomy for cancer, DIGEST SURG, 16(5), 1999, pp. 389-392

Authors: Ohlsson, B Fredang, N Axelson, J
Citation: B. Ohlsson et al., The effect of bombesin, cholecystokinin, gastrin, and their antagonists onproliferation of pancreatic cancer cell lines, SC J GASTR, 34(12), 1999, pp. 1224-1229

Authors: Axelson, J Jansen, C Sternby, B Bjorkman, A Rehfeld, JF Ihse, I
Citation: J. Axelson et al., Pancreatic growth after pancreatico-biliary diversion does not increase the capacity to secrete amylase, EUR SURG RE, 31(2), 1999, pp. 187-195

Authors: Ohlsson, B Borg, K Rehfeld, JF Ihse, I Axelson, J
Citation: B. Ohlsson et al., The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas, INT J PANCR, 24(3), 1998, pp. 211-218

Authors: Ohlsson, B Rehfeld, JF Axelson, J
Citation: B. Ohlsson et al., An evaluation of the influence of devazepide and CCK-8S on the intact and resected rat liver, EUR SURG RE, 30(6), 1998, pp. 378-384
Risultati: 1-17 |